应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02359 药明康德
已收盘 11-13 16:08:17
191.600
-9.800
-4.87%
最高
201.600
最低
189.000
成交量
504.66万
今开
197.300
昨收
201.400
日振幅
6.26%
总市值
5,777亿
流通市值
1,037亿
总股本
30.15亿
成交额
9.77亿
换手率
0.93%
流通股本
5.41亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
异动解读|药明康德盘中下跌3.03%,移出1260H名单后资金继续审视后续监管变量
行情直击 · 11:35
异动解读|药明康德盘中下跌3.03%,移出1260H名单后资金继续审视后续监管变量
药明康德(603259)11月12日主力资金净买入1.07亿元
证券之星 · 08:19
药明康德(603259)11月12日主力资金净买入1.07亿元
港股异动 | 药明康德(02359.HK)涨超3% 近期获移出美国1260H清单 公司在化学药CDMO领域具领先优势
智通财经 · 11-12 11:33
港股异动 | 药明康德(02359.HK)涨超3% 近期获移出美国1260H清单 公司在化学药CDMO领域具领先优势
异动解读|药明康德盘中上涨3.15%,机构看好移出1260H名单后续风险缓释
行情直击 · 11-12 11:02
异动解读|药明康德盘中上涨3.15%,机构看好移出1260H名单后续风险缓释
小摩:维持药明康德(02359.HK)“增持”评级及233港元目标价 移出美国1260H清单符合预期
智通财经 · 11-11 14:27
小摩:维持药明康德(02359.HK)“增持”评级及233港元目标价 移出美国1260H清单符合预期
异动解读|药明康德盘中下跌3.29%,移出1260H名单后资金转向审视后续监管变量
行情直击 · 11-11 10:09
异动解读|药明康德盘中下跌3.29%,移出1260H名单后资金转向审视后续监管变量
从药明康德事件看CRO产业链:跨境监管变量如何传导至订单与产能布局
同花顺 · 11-11 00:38
从药明康德事件看CRO产业链:跨境监管变量如何传导至订单与产能布局
智通AH统计|11月10日
智通财经 · 11-10
智通AH统计|11月10日
高盛:维持药明康德(02359)“买入”评级 目标价251港元
智通财经 · 11-10
高盛:维持药明康德(02359)“买入”评级 目标价251港元
美国国防部将药明康德从“中国军工企业名单”中移除
澎湃新闻 · 11-10
美国国防部将药明康德从“中国军工企业名单”中移除
异动解读|药明康德盘中上涨4.65%,被美方移出1260H名单提振情绪
行情直击 · 11-10
异动解读|药明康德盘中上涨4.65%,被美方移出1260H名单提振情绪
药明康德(603259)11月9日主力资金净买入3.35亿元
证券之星 · 11-10
药明康德(603259)11月9日主力资金净买入3.35亿元
港股公告掘金 | 彼岸控股控股权将易主 拟获折让约26.75%提全购要约 11月10日复牌
智通财经 · 11-10
港股公告掘金 | 彼岸控股控股权将易主 拟获折让约26.75%提全购要约 11月10日复牌
药明康德确认被美方移出“1260H中国军工企业”名单
公告速递 · 11-10
药明康德确认被美方移出“1260H中国军工企业”名单
The Capital Group Companies, Inc.增持药明康德(02359)348.04万股 每股作价约203.97港元
智通财经 · 11-09
The Capital Group Companies, Inc.增持药明康德(02359)348.04万股 每股作价约203.97港元
The Capital Group Companies, Inc.增持药明康德(02359.HK)348.04万股 每股作价约203.97港元
智通财经 · 11-09
The Capital Group Companies, Inc.增持药明康德(02359.HK)348.04万股 每股作价约203.97港元
药明康德:陈民章减持,好仓比例降至0.28%
港股披露 · 11-09
药明康德:陈民章减持,好仓比例降至0.28%
贝莱德在药明康德的H股好仓比例上升0.28%至6.06%
南方财经网 · 11-09
贝莱德在药明康德的H股好仓比例上升0.28%至6.06%
药明康德:The Capital Group Companies, Inc.增持,好仓比例升至5.01%
港股披露 · 11-09
药明康德:The Capital Group Companies, Inc.增持,好仓比例升至5.01%
富瑞:维持药明康德(02359.HK)目标价215港元与“买入”评级 订单积压加速强化明年能见度
智通财经 · 11-09
富瑞:维持药明康德(02359.HK)目标价215港元与“买入”评级 订单积压加速强化明年能见度
加载更多
公司概况
公司名称:
药明康德
所属市场:
SEHK
上市日期:
--
主营业务:
无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产(CTDMO)业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。
发行价格:
--
{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":191.6,"timestamp":1794557297007,"preClose":201.4,"halted":0,"volume":5046592,"delay":0,"changeRate":-0.04865938430983124,"floatShares":541000000,"shares":3015000000,"eps":7.773432189427107,"marketStatus":"已收盘","change":-9.8,"latestTime":"11-13 16:08:17","open":197.3,"high":201.6,"low":189,"amount":976653335,"amplitude":0.062562,"askPrice":191.6,"askSize":400,"bidPrice":191.5,"bidSize":400,"shortable":3,"etf":0,"ttmEps":10.492467048251191,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":5,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":201.4,"dividendRate":0.012744,"openAndCloseTimeList":[[1794533400000,1794542400000],[1794546000000,1794556800000]],"volumeRatio":0.756803,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXA.HK","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":146.3,"timestamp":1794553200000,"preClose":150.34,"halted":0,"volume":27674400,"delay":0,"premium":"+11.36"},"impliedVol":0.5477,"impliedVolPercentile":0.8473},"requestUrl":"/m/hq/s/02359","defaultTab":"news","newsList":[{"id":"1173636058","title":"异动解读|药明康德盘中下跌3.03%,移出1260H名单后资金继续审视后续监管变量","url":"https://stock-news.laohu8.com/highlight/detail?id=1173636058","media":"行情直击","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173636058?lang=zh_cn&edition=full","pubTime":"2026-11-13 11:35","pubTimestamp":1794540942,"startTime":"0","endTime":"0","summary":"11月13日,药明康德盘中下跌3.03%,报195.3港元,成交额1.92亿港元。消息面上,公司虽已被美国国防部移出1260H名单,但市场对利好兑现后的持续性与后续跨境监管变量重新评估,压制股价表现。此前多家机构维持买入或增持评级,认为除名有助于缓释部分地缘政治风险;但机构同时提示,后续仍需关注BIOSECURE框架及美国行政管理预算局拟公布的BCC名单等不确定因素,且美国国防部公告亦保留基于新增或补充理由再次列入的可能。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"药明康德盘中下跌,监管变量仍待消化","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683549044","title":"药明康德(603259)11月12日主力资金净买入1.07亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2683549044","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683549044?lang=zh_cn&edition=full","pubTime":"2026-11-13 08:19","pubTimestamp":1794529148,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月12日收盘,药明康德报收于150.34元,上涨1.1%,换手率1.47%,成交量36.3万手,成交额54.17亿元。近5日资金流向一览见下表:药明康德融资融券信息显示,融资方面,当日融资买入3.31亿元,融资偿还3.94亿元,融资净偿还6299.08万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300009057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0501845795.SGD","603259","LU1770034418.SGD","LU1997245177.USD","LU0164865239.USD","LU0320764599.SGD","LU1979443071.USD","LU1969619763.USD","LU0327786744.USD","LU0871576103.HKD","LU2242644610.SGD","LU0106959298.USD","LU2328871848.SGD","LU0611395673.USD","LU2125910500.SGD","LU2045819591.USD","LU0455707207.USD","LU0181495838.USD","BK0216","02359","LU0469268626.HKD","LU1997244956.HKD","LU2495084118.USD","LU1655091616.SGD","BK1583","LU1997245094.SGD","LU0572944931.SGD","LU1303224171.USD","LU1808992512.USD","LU0039217434.USD","LU0502904849.HKD","IE00BPRC5H50.USD","LU0708995583.HKD","LU1934453819.USD","LU0348766576.USD","LU0456842615.SGD","LU0828237940.HKD","LU1255011170.USD","LU0052750758.USD","IE00B543WZ88.USD","BK1141","LU1481107354.HKD","LU0700851271.USD","LU1046422090.SGD","LU0348767384.USD","LU0164880469.USD","LU0531971595.HKD","LU0149721374.USD","LU1719994722.HKD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682537948","title":"港股异动 | 药明康德(02359.HK)涨超3% 近期获移出美国1260H清单 公司在化学药CDMO领域具领先优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2682537948","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682537948?lang=zh_cn&edition=full","pubTime":"2026-11-12 11:33","pubTimestamp":1794454426,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0501845795.SGD","LU0348766576.USD","LU0502904849.HKD","02359","LU0052750758.USD","LU0327786744.USD","BK1576","LU0572944931.SGD","BK1583","LU1481107354.HKD","LU2045819591.USD","LU0469268626.HKD","LU0455707207.USD","LU2125910500.SGD","LU0149721374.USD","LU0320764599.SGD","LU0708995583.HKD","LU2242644610.SGD","LU0072913022.USD","LU0164880469.USD","LU0348767384.USD","BK1141","LU1046422090.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169234005","title":"异动解读|药明康德盘中上涨3.15%,机构看好移出1260H名单后续风险缓释","url":"https://stock-news.laohu8.com/highlight/detail?id=1169234005","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169234005?lang=zh_cn&edition=full","pubTime":"2026-11-12 11:02","pubTimestamp":1794452572,"startTime":"0","endTime":"0","summary":"11月12日,药明康德盘中上涨3.15%,报202.8港元,成交额5.22亿港元。消息面上,公司被美国国防部移出1260H名单后,多家机构继续维持买入或增持评级,带动市场重新交易地缘政治风险缓释预期。不过机构同时提示,后续仍需关注BIOSECURE框架及BCC名单等监管变量。无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。生物学业务分部主要从事提供药物发现及研究服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明康德盘中上涨,移出名单风险缓释","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682373879","title":"小摩:维持药明康德(02359.HK)“增持”评级及233港元目标价 移出美国1260H清单符合预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2682373879","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682373879?lang=zh_cn&edition=full","pubTime":"2026-11-11 14:27","pubTimestamp":1794378464,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0149721374.USD","LU0348766576.USD","LU0072913022.USD","BK1583","LU0164880469.USD","LU0572944931.SGD","LU0708995583.HKD","LU0501845795.SGD","LU2242644610.SGD","LU2045819591.USD","LU0469268626.HKD","LU0348767384.USD","02359","BK1141","LU1046422090.SGD","LU0502904849.HKD","LU0455707207.USD","LU1481107354.HKD","LU2125910500.SGD","LU0320764599.SGD","LU0327786744.USD","BK1576","LU0052750758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176925165","title":"异动解读|药明康德盘中下跌3.29%,移出1260H名单后资金转向审视后续监管变量","url":"https://stock-news.laohu8.com/highlight/detail?id=1176925165","media":"行情直击","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176925165?lang=zh_cn&edition=full","pubTime":"2026-11-11 10:09","pubTimestamp":1794362971,"startTime":"0","endTime":"0","summary":"11月11日,药明康德盘中下跌3.29%,报193.8港元,成交额3.58亿港元。消息面上,公司此前虽已被美国国防部移出1260H名单,但该决定系遵从法院初步禁令命令,且公告明确为不影响未来基于补充理由再次列入;市场对利好兑现后的持续性与跨境监管后续影响重新评估。同时,公开讨论显示,名单移除更多属于程序性节点解除,并不等同于中美生物技术监管摩擦全面缓和;叠加美国对生物技术投资审查规则仍在推进,CXO板块情绪同步承压,同行药明生物、药明合联亦走弱。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"药明康德盘中走弱,监管变量再引审视","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682314225","title":"从药明康德事件看CRO产业链:跨境监管变量如何传导至订单与产能布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2682314225","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682314225?lang=zh_cn&edition=full","pubTime":"2026-11-11 00:38","pubTimestamp":1794328680,"startTime":"0","endTime":"0","summary":"药明康德被移出美国军工企业名单,事件走完了司法程序。市场第一反应容易把它读成“利空出颈,但放在CRO/CDMO产业链的跨境监管变量图谱里,这只是一个特定程序性节点的解除,远不是全部监管 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261111/c681677082.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261111/c681677082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU0871576103.HKD","LU0531971595.HKD","LU1046422090.SGD","LU0348766576.USD","603259","LU2495084118.USD","LU0181495838.USD","IE00B5MMRT66.SGD","02359","LU0469268626.HKD","MVPS","LU0072913022.USD","LU0502904849.HKD","LU1979443071.USD","LU1481107354.HKD","LU0572944931.SGD","LU1303224171.USD","LU2242644610.SGD","VGRSF","LU1655091616.SGD","LU0164880469.USD","LU0106959298.USD","LU0501845795.SGD","LU1969619763.USD","BK1583","LU0348767384.USD","LU0455707207.USD","LU0456842615.SGD","LU1808992512.USD","LU0149721374.USD","LU0828237940.HKD","BK1576","LU1719994722.HKD","LU0327786744.USD","LU2488822045.USD","LU0164865239.USD","LU1934453819.USD","LU2328871848.SGD","BK1141","LU0700851271.USD","LU1251922891.USD","IE00B543WZ88.USD","LU0039217434.USD","LU1997244956.HKD","LU0320764599.SGD","LU1255011170.USD","LU1770034418.SGD","LU0611395673.USD","LU2045819591.USD","AADR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682623393","title":"智通AH统计|11月10日","url":"https://stock-news.laohu8.com/highlight/detail?id=2682623393","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682623393?lang=zh_cn&edition=full","pubTime":"2026-11-10 16:15","pubTimestamp":1794298504,"startTime":"0","endTime":"0","summary":"东北电气0.2012.251243.28%-5.51%晨鸣纸业0.4251.86424.71%69.45%浙江世宝3.48015.05418.10%7.50%凯盛新能1.8056.92359.28%9.14%弘业期货1.9057.13348.29%-7.78%京城机电股份2.4258.29309.48%26.57%中石化油服0.6402.07287.50%-6.77%南京熊猫电子股份2.9259.38284.27%-1.71%广和通6.67521.35283.07%22.05%钧达股份15.40048.9280.32%-12.46%. 兆威机电33.960107277.39%82.65%晨鸣纸业0.4251.86424.71%69.45%蓝思科技14.66029.17138.34%40.37%京城机电股份2.4258.29309.48%26.57%中芯国际47.240107.75173.20%26.30%长飞光纤光缆89.700252.33236.95%22.63%广和通6.67521.35283.07%22.05%大族数控50.200140.48235.20%22.00%龙旗科技19.39040.12147.86%21.75%长城汽车6.20513.77165.75%19.63%. 备注:以上数据由智通机器人根据港交所数据,经过人工智能运算后自动生成,并不保证数据100%准确;偏离值为当前溢价率与该股过去30天平均溢价率的差值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1521021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02384","GWLLY","03661","00187","00300","02338","02603","02245","02333","01057","03328","02823","01033","02827","EWH","00042","03986","00916","02359","00956","01349","03369","00553","07233","06613","159982","02768","06869","601633","399300","00588","01812","02899","03678","03750","02692","03143","82333","00638","03200","03308","02822","01276","02865","03968","09611","01108","03188","00981"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682361232","title":"高盛:维持药明康德(02359)“买入”评级 目标价251港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682361232","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682361232?lang=zh_cn&edition=full","pubTime":"2026-11-10 15:33","pubTimestamp":1794295989,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,高盛发布研报称,药明康德于11月6日举行年度投资者日,活动整体内容符合该行预期,公司进一步展示在技术能力、研发管线及营运效率方面的进展,并未对财务预测作出更新;该行给予药明康德“买入”评级,目标价251港元。药明康德整合化学、生物学与药物代谢的能力,正好作为此模式中的湿实验室组件,大规模地将电脑模拟假设转化为实际化合物与实验数据。目前约有20个车间处于交付、建设或规划阶段。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","603259","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682350314","title":"美国国防部将药明康德从“中国军工企业名单”中移除","url":"https://stock-news.laohu8.com/highlight/detail?id=2682350314","media":"澎湃新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682350314?lang=zh_cn&edition=full","pubTime":"2026-11-10 12:14","pubTimestamp":1794284040,"startTime":"0","endTime":"0","summary":"公告称,美国国防部副部长认定应遵从法院批准对公司初步禁令动议的裁决命令,将药明康德从国防部更新的名单中移除。今年6月8日,美国国防部扩大所谓“中国军工企业名单”,新增药明康德、阿里巴巴、比亚迪等多家中国企业。药明康德随后在6月11日起诉美国国防部,要求将公司名字从涉军中企名单中移除。美国联邦地区法官博斯伯格8月7日签发命令,阻止美国国防部在诉讼进行期间执行今年6月将药明康德列入黑名单的决定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-11-10/doc-iniyfkmf2780080.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-11-10/doc-iniyfkmf2780080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1997245177.USD","LU1997244956.HKD","LU1303224171.USD","LU2045819591.USD","LU2242644610.SGD","LU1979443071.USD","02359","LU0708995583.HKD","161024","LU0456842615.SGD","LU0149721374.USD","LU0320764599.SGD","LU0469268626.HKD","IE00BPRC5H50.USD","LU0502904849.HKD","LU1255011170.USD","LU0871576103.HKD","LU0164865239.USD","IE00B543WZ88.USD","LU0611395673.USD","LU1481107354.HKD","LU1251922891.USD","LU1808992512.USD","LU1046422090.SGD","LU1719994722.HKD","LU1997245094.SGD","LU1655091616.SGD","LU2328871848.SGD","LU0828237940.HKD","BK1141","LU2125910500.SGD","LU0572944931.SGD","LU0700851271.USD","603259","LU0327786744.USD","LU1770034418.SGD","LU2495084118.USD","LU1969619763.USD","BK0216","BK1583","SHLD","LU0348766576.USD","LU0348767384.USD","BK1576","LU0501845795.SGD","LU2488822045.USD","LU0531971595.HKD","LU0072913022.USD","LU0164880469.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103959568","title":"异动解读|药明康德盘中上涨4.65%,被美方移出1260H名单提振情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1103959568","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103959568?lang=zh_cn&edition=full","pubTime":"2026-11-10 09:31","pubTimestamp":1794274319,"startTime":"0","endTime":"0","summary":"11月10日,药明康德盘中上涨4.65%,报206.6港元,成交额1.57亿港元。消息面上,公司公告称,美国国防部已于11月9日决定将其从1260H项下中国军工企业名单中移除,直接缓解了相关认定带来的不利影响。此前公司曾就被列入名单提起诉讼;最新公告显示,国防部副部长决定遵从法院就初步禁令动议的命令,将公司移出名单。叠加近期获The Capital Group增持348.04万股、贝莱德好仓比例升至6.06%,进一步强化市场风险偏好。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明康德上涨,被美方移出1260H名单","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682335516","title":"药明康德(603259)11月9日主力资金净买入3.35亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682335516","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682335516?lang=zh_cn&edition=full","pubTime":"2026-11-10 09:15","pubTimestamp":1794273321,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月9日收盘,药明康德报收于150.29元,上涨2.24%,换手率1.16%,成交量28.63万手,成交额43.17亿元。近5日资金流向一览见下表:药明康德融资融券信息显示,融资方面,当日融资买入2.68亿元,融资偿还3.53亿元,融资净偿还8543.02万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000010570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0502904849.HKD","LU0611395673.USD","LU0455707207.USD","LU0164880469.USD","LU0708995583.HKD","LU0572944931.SGD","BK1141","LU0348766576.USD","LU1303224171.USD","LU0828237940.HKD","LU0871576103.HKD","LU2125910500.SGD","LU2242644610.SGD","LU1481107354.HKD","IE00B5MMRT66.SGD","LU1997244956.HKD","LU0456842615.SGD","LU1997245177.USD","LU1255011170.USD","LU0181495838.USD","LU1934453819.USD","LU2488822045.USD","LU0469268626.HKD","LU0164865239.USD","LU0072913022.USD","LU1655091616.SGD","LU0106959298.USD","BK1576","LU1719994722.HKD","LU0327786744.USD","LU0501845795.SGD","LU1046422090.SGD","LU2328871848.SGD","LU0348767384.USD","02359","LU2045819591.USD","603259","LU1997245094.SGD","LU1251922891.USD","BK0216","BK1583","LU0039217434.USD","LU0531971595.HKD","LU1969619763.USD","IE00BPRC5H50.USD","LU2495084118.USD","LU0149721374.USD","IE00B543WZ88.USD","LU1770034418.SGD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682355302","title":"港股公告掘金 | 彼岸控股控股权将易主 拟获折让约26.75%提全购要约 11月10日复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2682355302","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682355302?lang=zh_cn&edition=full","pubTime":"2026-11-10 08:42","pubTimestamp":1794271345,"startTime":"0","endTime":"0","summary":"【重大事项】中国软件国际(00354)成功中标东南亚头部银行企业级数据现代化亿级总集成项目华新建材(06655):华新长阳拟6400万元将水泥熟料产能指标转让给宜化楚星金源氢化(02502)已开展关于扩充粗苯加氢产能及改造相关设备的项目方达控股(01521)获溢价约59.1%题私有化 11月10日复牌医渡科技(02158):联属公司中标同济医院中法新城院区续建配套工程项目数智化平台优然牧业(098","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520815.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0469268626.HKD","BK1589","LU0455707207.USD","BK1518","09995","LU0320764599.SGD","LU0164880469.USD","LU0572944931.SGD","BK1526","BK1141","LU1969619763.USD","LU0327786744.USD","01521","02359","LU0072913022.USD","LU0502904849.HKD","LU0348766576.USD","KCAI","LU1481107354.HKD","00354","BK1583","BK1576","LU0149721374.USD","LU2328871848.SGD","LU0501845795.SGD","LU0052750758.USD","LU1046422090.SGD","LU0348767384.USD","BK4585","LU2242644610.SGD","BK1574","BK1155","BK4588","02885","BK1179","LU0708995583.HKD","LU2125910500.SGD","BK1161","LU2045819591.USD","VXUS","BK1586"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194473098","title":"药明康德确认被美方移出“1260H中国军工企业”名单","url":"https://stock-news.laohu8.com/highlight/detail?id=1194473098","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194473098?lang=zh_cn&edition=full","pubTime":"2026-11-10 07:45","pubTimestamp":1794267947,"startTime":"0","endTime":"0","summary":"2026年11月10日,无锡药明康德新药开发股份有限公司发布自愿公告称,美国国防部已于2026年11月9日决定将公司从《2023年国防授权法案》第1260H条款所列“中国军工企业”名单中移除。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682802367","title":"The Capital Group Companies, Inc.增持药明康德(02359)348.04万股 每股作价约203.97港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682802367","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682802367?lang=zh_cn&edition=full","pubTime":"2026-11-09 19:13","pubTimestamp":1794222782,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,11月5日,The Capital Group Companies, Inc.增持药明康德(02359)348.04万股,每股作价203.9726港元,总金额约为7.10亿港元。增持后最新持股数目约为2710.33万股,最新持股比例为5.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520593.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348766576.USD","LU0502904849.HKD","LU2045819591.USD","LU1969619763.USD","LU2328871848.SGD","LU1997245094.SGD","LU0149721374.USD","LU0531971595.HKD","LU1979443071.USD","LU0327786744.USD","EWH","LU0708995583.HKD","LU0072913022.USD","LU0039217434.USD","LU0469268626.HKD","LU0828237940.HKD","LU0455707207.USD","LU1770034418.SGD","BK1576","IE00B5MMRT66.SGD","LU1046422090.SGD","BK1583","02359","LU1303224171.USD","LU1251922891.USD","LU0320764599.SGD","LU0871576103.HKD","LU1481107354.HKD","IE00BPRC5H50.USD","LU0106959298.USD","LU2495084118.USD","LU1255011170.USD","LU1997245177.USD","LU1655091616.SGD","LU0348767384.USD","LU1934453819.USD","LU0456842615.SGD","LU0501845795.SGD","LU0700851271.USD","IE00B543WZ88.USD","LU1719994722.HKD","LU0052750758.USD","603259","LU2242644610.SGD","LU0611395673.USD","LU0164880469.USD","BK1141","BK0216","LU2488822045.USD","LU0164865239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682802363","title":"The Capital Group Companies, Inc.增持药明康德(02359.HK)348.04万股 每股作价约203.97港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682802363","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682802363?lang=zh_cn&edition=full","pubTime":"2026-11-09 19:13","pubTimestamp":1794222782,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1481107354.HKD","LU0708995583.HKD","LU2125910500.SGD","LU0348767384.USD","LU0501845795.SGD","LU1046422090.SGD","02359","LU2242644610.SGD","BK1583","LU0348766576.USD","LU0052750758.USD","BK1576","LU0164880469.USD","LU0327786744.USD","LU0072913022.USD","LU0572944931.SGD","LU0149721374.USD","LU0469268626.HKD","LU0320764599.SGD","BK1141","LU2045819591.USD","LU0455707207.USD","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143582323","title":"药明康德:陈民章减持,好仓比例降至0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143582323","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143582323?lang=zh_cn&edition=full","pubTime":"2026-11-09 17:32","pubTimestamp":1794216758,"startTime":"0","endTime":"0","summary":"陈民章于2026年11月6日在联交所场内以每股均价196.6959港元卖出药明康德(02359)股份10.59万股,涉资约2083.09万港元,所涉股份来自由香港中央证券信托有限公司管理的公司H股奖励信托计划项下的股份出售,属场内主动交易,即在二级市场直接买卖股份。陈民章此次减持前持有药明康德好仓173.30万,占比0.3%;减持后持股量为162.71万,好仓比例降至0.28%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682780517","title":"贝莱德在药明康德的H股好仓比例上升0.28%至6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682780517","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682780517?lang=zh_cn&edition=full","pubTime":"2026-11-09 17:21","pubTimestamp":1794216117,"startTime":"0","endTime":"0","summary":"21财经11月9日电,香港交易所披露信息显示,BlackRock,Inc.(贝莱德)在药明康德的H股好仓(L)比例于11月4日从5.78%上升至6.06%。同时淡仓(S)比例从0.22%降至0.21%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611093926325263.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611093926325263.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1303224171.USD","IE00BPRC5H50.USD","LU1719994722.HKD","LU0348766576.USD","LU1251922891.USD","LU2495084118.USD","BK1583","LU2125910500.SGD","LU0456842615.SGD","LU0700851271.USD","LU1808992512.USD","LU0708995583.HKD","BK1141","BK0216","LU0502904849.HKD","LU2045819591.USD","LU0871576103.HKD","LU0164880469.USD","LU0455707207.USD","LU0149721374.USD","LU0052750758.USD","LU1979443071.USD","LU0072913022.USD","LU0320764599.SGD","LU0501845795.SGD","02359","LU0828237940.HKD","LU1997244956.HKD","LU0327786744.USD","LU1969619763.USD","LU1997245177.USD","LU1655091616.SGD","LU1255011170.USD","LU1046422090.SGD","LU2488822045.USD","LU2242644610.SGD","LU0164865239.USD","LU0181495838.USD","BK1576","LU1481107354.HKD","IE00B543WZ88.USD","LU0106959298.USD","LU0348767384.USD","LU2328871848.SGD","603259","LU1997245094.SGD","LU0469268626.HKD","LU0611395673.USD","LU0572944931.SGD","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113873720","title":"药明康德:The Capital Group Companies, Inc.增持,好仓比例升至5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113873720","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113873720?lang=zh_cn&edition=full","pubTime":"2026-11-09 17:14","pubTimestamp":1794215686,"startTime":"0","endTime":"0","summary":"The Capital Group Companies, Inc.于2026年11月5日在联交所场内以每股均价203.9726港元买入药明康德(02359)股份348.04万股,涉资约7.10亿港元,属场内主动交易,即在二级市场直接买卖股份。The Capital Group Companies, Inc.此次增持前持有药明康德好仓2362.29万,占比4.36%;增持后持股量为2710.33万,好仓比例升至5.01%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682717168","title":"富瑞:维持药明康德(02359.HK)目标价215港元与“买入”评级 订单积压加速强化明年能见度","url":"https://stock-news.laohu8.com/highlight/detail?id=2682717168","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682717168?lang=zh_cn&edition=full","pubTime":"2026-11-09 14:30","pubTimestamp":1794205844,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0708995583.HKD","LU0164880469.USD","LU2125910500.SGD","LU0501845795.SGD","LU0455707207.USD","LU2242644610.SGD","LU0072913022.USD","LU0502904849.HKD","LU2045819591.USD","LU0327786744.USD","LU0052750758.USD","LU0572944931.SGD","BK1583","LU1046422090.SGD","LU0149721374.USD","LU0348767384.USD","BK1141","LU0348766576.USD","LU1481107354.HKD","BK1576","02359","LU0469268626.HKD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":-0.0147},{"period":"1month","weight":-0.0289},{"period":"3month","weight":0.0232},{"period":"6month","weight":0.5792},{"period":"1year","weight":1.0202},{"period":"ytd","weight":1.0734}],"compareEarnings":[{"period":"1week","weight":-0.0318},{"period":"1month","weight":-0.0138},{"period":"3month","weight":-0.0441},{"period":"6month","weight":-0.0753},{"period":"1year","weight":-0.1082},{"period":"ytd","weight":-0.0633}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产(CTDMO)业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.026729},{"month":2,"riseRate":0.5,"avgChangeRate":0.002973},{"month":3,"riseRate":0.375,"avgChangeRate":-0.010735},{"month":4,"riseRate":0.5,"avgChangeRate":0.006501},{"month":5,"riseRate":0.375,"avgChangeRate":-0.004537},{"month":6,"riseRate":0.75,"avgChangeRate":0.089541},{"month":7,"riseRate":0.75,"avgChangeRate":0.092416},{"month":8,"riseRate":0.625,"avgChangeRate":0.059692},{"month":9,"riseRate":0.625,"avgChangeRate":0.094161},{"month":10,"riseRate":0.375,"avgChangeRate":-0.019352},{"month":11,"riseRate":0.375,"avgChangeRate":0.008215},{"month":12,"riseRate":0.571429,"avgChangeRate":0.03824}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}